期刊文献+

基于FAERS数据库的注射用紫杉醇(白蛋白结合型)不良事件真实世界研究

Real-world study of adverse events of paclitaxel for injection(albumin bound)based on the FAERS database
下载PDF
导出
摘要 目的挖掘真实世界中注射用紫杉醇(白蛋白结合型)相关不良事件(ADE)信号,为临床安全合理用药提供参考。方法在美国食品药品监督管理局不良事件报告系统(FAERS)中检索2004年第1季度至2023年第3季度注射用紫杉醇(白蛋白结合型)的ADE报告,采用报告比值比(ROR)法和贝叶斯可信区间递进神经网络(BCPPN)算法进行信号挖掘,分析其在真实世界中的ADE发生情况。结果共检测到200个ADE信号,累及22个系统器官分类(SOC),合计报告5061份,其中女性占比高于男性,年龄主要分布在45岁以上。累及SOC主要包括全身性疾病及给药部位各种反应(23.43%)、血液和淋巴系统疾病(18.55%)、胃肠系统疾病(10.06%)、各类检查(8.32%)、代谢与营养类疾病(5.97%)、各类神经系统疾病(5.10%)等。报告数较多的ADE信号包括嗜中性粒细胞减少症、贫血、血小板减少症、发热性中性粒细胞减少、周围神经病变、脓毒症等;相关性较强的ADE信号主要包括胆道感染、周围感觉神经病变、免疫介导性肝炎、胆管狭窄、黄斑水肿等。挖掘到30个说明书未记录的新型可疑不良反应(ADR),主要包括淋巴细胞减少、心理状态改变、高血糖症、食管炎、多发性神经病等。结论注射用紫杉醇(白蛋白结合型)在真实世界中的常见不良反应与说明书具有一致性,但存在部分新发现的可疑不良反应,临床用药时应重点关注此类不良反应。 Objective To explore the adverse drug event(ADE)signals associated with paclitaxel for injection(albumin bound)in the real world,in order to provide references for clinically rational and safe medication.Methods ADE reports of paclitaxel for injection(albumin bound)from the first quarter of 2004 to the third quarter of 2023 were retrieved from the FDA Adverse Event Reporting System(FAERS).The reporting odds ratio(ROR)method and the Bayesian confidence propagation neural network(BCPNN)method were used to find signals and study how ADEs happen in the real world.Results A total of 200 ADE signals were detected,involving 22 system organ classes(SOC),with 5061 reports in total.A higher proportion of reports were from females than from males,and the reports were mainly from individuals aged 45 and above.The accumulated SOCs mainly included general disorders and administration site conditions(23.43%),blood and lymphatic system disorders(18.55%),gastrointestinal disorders(10.06%),various examinations(8.32%),metabolic and nutritional disorders(5.97%),and various neurological disorders(5.10%),etc.Neutropenia,anemia,thrombocytopenia,febrile neutropenia,peripheral neuropathy,and sepsis were the ADE signals that were reported the most.On the other hand,ADE signals with strong correlation mainly included biliary infection,peripheral sensory neuropathy,immune-mediated hepatitis,bile duct stenosis,macular edema,etc.A total of 30 new suspected adverse reactions(ADR)not recorded in the drug instruction were found,mainly including lymphopenia,changes in mental status,hyperglycemia,esophagitis,multiple neuropathies,etc.Conclusion The common adverse reactions of paclitaxel for injection(albumin bound)in the real world were consistent with those listed in the drug instruction,but there were some newly discovered suspected adverse reactions.These should be paid special attention to in clinical medication.
作者 段远琼 王文翔 杨琳 尹如铁 DUAN Yuanqiong;WANG Wenxiang;YANG Lin;YIN Rutie(Department of Obstetrics and Gynecology,West China Second Hospital of Sichuan University,Chengdu,610041,Sichuan,China;Key Laboratory of Birth Defects and Related Diseases of Women and Children(Sichuan University),Ministry of Education,Chengdu,610041,Sichuan,China)
出处 《肿瘤药学》 CAS 2024年第2期209-216,共8页 Anti-Tumor Pharmacy
基金 四川省科学技术厅重点研发项目(2019YFS0532) 成都市科技局项目(2021-YF05-01725-SN)。
关键词 注射用紫杉醇(白蛋白结合型) 药物不良事件 FDA不良事件报告系统 信号挖掘 药物警戒分析 Paclitaxel for injection(albumin bound) Adverse drug events FDA Adverse Event Reporting System Signal mining Pharmacovigilance analysis
  • 相关文献

参考文献5

二级参考文献30

共引文献100

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部